CYP19A1 and infection: As previous studies have demonstrated the relationship between overgrowth of gastrointestinal Pseudomonadota, other pathogens, and ARO carriage with infection risk (3, -, 6) as well as ARG abundance and ARO colonization (22), we aimed to assess the impact of administration of a microbial consortium, microbial ecosystem therapeutic (MET-2), on members of Pseudomonadota and ARG abundance.